Lebanon Sci-Tech Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Lebanon Sci-Tech Weekly.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 18, 2025

December 18, 2025

Genius Group Engages DLA Piper as Advisor on Australian Securities Exchange (ASX) Dual Listing.

GlobeNewswire

December 18, 2025

Rezolve Ai Warns Generic LLM Chatbots Are Embarrassing Global Brands After The Gap, Inc. Incident

GlobeNewswire

December 18, 2025

Werewolf Therapeutics Announces Pipeline and Business Updates

GlobeNewswire

December 18, 2025

Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform

GlobeNewswire

December 18, 2025

“Eleven clinical trials that will shape medicine in 2026” – BriaCell Phase 3 Trial Featured in Nature Medicine

GlobeNewswire

December 18, 2025

Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference

GlobeNewswire

December 18, 2025

ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease

GlobeNewswire

December 18, 2025

ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease

GlobeNewswire

December 18, 2025

Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company

GlobeNewswire

December 18, 2025

CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock

GlobeNewswire

December 18, 2025

NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion

GlobeNewswire

December 18, 2025

Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million

GlobeNewswire

December 18, 2025

Memo Therapeutics AG’s Potravitug Granted Orphan Designation in the European Union

GlobeNewswire

December 18, 2025

FactSet Reports Results for First Quarter Fiscal 2026

GlobeNewswire

December 18, 2025

Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

GlobeNewswire

December 18, 2025

CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries

GlobeNewswire

December 18, 2025

Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender

GlobeNewswire

December 18, 2025

ONAR Holding Corporation Retires $311,000 in Debt Through Equity Conversion, Strengthens Balance Sheet, and Aligns Long-Term Partners with Shareholders

GlobeNewswire

December 18, 2025

BitMart Launches Christmas Mega Giveaway with Over 1,000,000 USDT in Rewards

GlobeNewswire

December 18, 2025

Atavistik Bio Raises $120 Million Series B Financing to Advance the Development of Selective Allosteric Small Molecule Therapeutics for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT) and Myeloproliferative Neoplasms (MPNs)

GlobeNewswire